4 February 2025 - Public Launch of SISAQOL-IMI Recommendations

The Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints – Innovative Medicines Initiative (SISAQOL-IMI) consortium will hold its public launch on February 4, 2025

- Public Launch of SISAQOL-IMI Recommendations - February 4, 2025. The Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints – Innovative Medicines Initiative (SISAQOL-IMI) consortium will hold its public launch on February 4, 2025, during the concluding Consensus Meeting. This event is open to external stakeholders and will feature key highlights from the recommendations, examples of stakeholder implementations, and a panel discussion on how various stakeholders can contribute to implementing the SISAQOL-IMI recommendations in cancer clinical trials.

For online participation please register until January 31st, 2025.

Se info om program og påmelding